These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 14510969)

  • 1. Onychomycosis in clinical practice: factors contributing to recurrence.
    Scher RK; Baran R
    Br J Dermatol; 2003 Sep; 149 Suppl 65():5-9. PubMed ID: 14510969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Onychomycosis in the elderly.
    Gupta AK
    Drugs Aging; 2000 Jun; 16(6):397-407. PubMed ID: 10939306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric Onychomycosis: The Emerging Role of Topical Therapy.
    Eichenfield LF; Friedlander SF
    J Drugs Dermatol; 2017 Feb; 16(2):105-109. PubMed ID: 28300851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical antifungal drugs for the treatment of onychomycosis: an overview of current strategies for monotherapy and combination therapy.
    Baran R; Kaoukhov A
    J Eur Acad Dermatol Venereol; 2005 Jan; 19(1):21-9. PubMed ID: 15649187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Onychomycosis in the elderly : drug treatment options.
    Loo DS
    Drugs Aging; 2007; 24(4):293-302. PubMed ID: 17432924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal agents for onychomycosis: new treatment strategies to improve safety.
    Zane LT; Chanda S; Coronado D; Del Rosso J
    Dermatol Online J; 2016 Mar; 22(3):. PubMed ID: 27136621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Onychomycosis: Diagnosis and management.
    Singal A; Khanna D
    Indian J Dermatol Venereol Leprol; 2011; 77(6):659-72. PubMed ID: 22016272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of surgical avulsion and topical therapy for single nail onychomycosis: a randomized controlled trial.
    Grover C; Bansal S; Nanda S; Reddy BS; Kumar V
    Br J Dermatol; 2007 Aug; 157(2):364-8. PubMed ID: 17573877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of antifungal therapy and the severity index for assessing onychomycosis: part I.
    Baran R; Hay RJ; Garduno JI
    J Dermatolog Treat; 2008; 19(2):72-81. PubMed ID: 18484426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Onychomycosis in Older Adults: Prevalence, Diagnosis, and Management.
    Gupta AK; Venkataraman M; Talukder M
    Drugs Aging; 2022 Mar; 39(3):191-198. PubMed ID: 35102533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is Severity of Disease a Prognostic Factor for Cure Following Treatment of Onychomycosis?
    Elewski BE; Cantrell W; Lin T
    J Drugs Dermatol; 2018 Feb; 17(2):175-178. PubMed ID: 29462225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ciclopirox nail lacquer: a brush with onychomycosis.
    Gupta AK
    Cutis; 2001 Aug; 68(2 Suppl):13-6. PubMed ID: 11665723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical challenge of onychomycosis.
    Meehan KJ; Miller C
    JAAPA; 2001 Apr; 14(4):43-6, 49-50. PubMed ID: 11521365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of toenail onychomycosis.
    Tom CM; Kane MP
    Am J Health Syst Pharm; 1999 May; 56(9):865-71. PubMed ID: 10344609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Routes of drug delivery into the nail apparatus: Implications for the efficacy of topical nail solutions in onychomycosis.
    Gupta AK; Simpson FC
    J Dermatolog Treat; 2016; 27(1):2-4. PubMed ID: 25983025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tavaborole for the treatment of onychomycosis.
    Elewski BE; Tosti A
    Expert Opin Pharmacother; 2014 Jul; 15(10):1439-48. PubMed ID: 24856836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging topical onychomycosis therapies - quo vadis?
    Elkeeb R; Hui X; Murthy N; Maibach HI
    Expert Opin Emerg Drugs; 2014 Dec; 19(4):489-95. PubMed ID: 25401504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of onychomycosis: examining the role of monotherapy and dual, triple, or quadruple therapies.
    Gupta AK; Lynch LE
    Cutis; 2004 Jul; 74(1 Suppl):5-9. PubMed ID: 15287394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy, safety and tolerability of an optimized avulsion technique with onyster® (40% urea ointment with plastic dressing) ointment compared to bifonazole-urea ointment for removal of the clinically infected nail in toenail onychomycosis: a randomized evaluator-blinded controlled study.
    Lahfa M; Bulai-Livideanu C; Baran R; Ortonne JP; Richert B; Tosti A; Piraccini BM; Szepietowski JC; Sibaud V; Coubetergues H; Voisard JJ; Paul C
    Dermatology; 2013; 226(1):5-12. PubMed ID: 23467055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New pharmacotherapy for the treatment of onychomycosis: an update.
    Gupta AK; Simpson FC
    Expert Opin Pharmacother; 2015 Feb; 16(2):227-36. PubMed ID: 25522979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.